blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1893997

EP1893997 - QUANTITATIVE ASSAYS FOR RAS P21 IN BODY FLUIDS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.06.2011
Database last updated on 15.06.2024
Most recent event   Tooltip04.10.2013Lapse of the patent in a contracting state
New state(s): HU		published on 06.11.2013  [2013/45]
Applicant(s)For all designated states
Siemens Healthcare Diagnostics Inc.
511 Benedict Avenue
Tarrytown, NY 10591 / US
[2008/28]
Former [2008/10]For all designated states
Bayer Healthcare LLC
Law & Patens Department 511 Benedict Avenue
Tarrytown, NY 10591 / US
Inventor(s)01 / CARNEY, Walter, P.
14 Bay State Road
North Andover, MA 01845 / US
02 / HAMER, Peter, J.
25 Dudley Street
Reading, MA 01867 / US
03 / PIERCE, Karen
3 Heald Road
Acton, MA 01720 / US
04 / BROWN-SHIMER, Sheryl
14 Rutland Street
Boston, MA 02188 / US
 [2008/10]
Representative(s)Maier, Daniel Oliver, et al
Siemens AG
Postfach 22 16 34
80506 München / DE
[N/P]
Former [2009/13]Maier, Daniel Oliver, et al
Siemens AG CT IP Postfach 22 16 34
80506 München / DE
Former [2008/10]Behnisch, Werner
Reinhard-Skuhra-Weise & Partner GbR Friedrichstrasse 31
80801 München / DE
Application number, filing date06785512.223.06.2006
[2008/10]
WO2006US24647
Priority number, dateUS20050694082P23.06.2005         Original published format: US 694082 P
[2008/10]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2007002505
Date:04.01.2007
Language:EN
[2007/01]
Type: A1 Application with search report 
No.:EP1893997
Date:05.03.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 04.01.2007 takes the place of the publication of the European patent application.
[2008/10]
Type: B1 Patent specification 
No.:EP1893997
Date:04.08.2010
Language:EN
[2010/31]
Search report(s)International search report - published on:US04.01.2007
(Supplementary) European search report - dispatched on:EP21.01.2009
ClassificationIPC:G01N33/48, G01N33/00, G01N1/00
[2008/10]
CPC:
G01N33/5748 (EP,US); G01N33/574 (US); G01N2333/82 (EP,US);
G01N2800/44 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/10]
Extension statesRSNot yet paid
TitleGerman:QUANTITATIVE ASSAYS FÜR RAS P21 IN KÖRPERFLÜSSIGKEITEN[2008/10]
English:QUANTITATIVE ASSAYS FOR RAS P21 IN BODY FLUIDS[2008/10]
French:ESSAIS QUANTITATIFS DE RECHERCHE DE RAS P21 DANS LES FLUIDES CORPORELS[2008/10]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase19.12.2007National basic fee paid 
19.12.2007Search fee paid 
19.12.2007Designation fee(s) paid 
19.12.2007Examination fee paid 
Examination procedure19.12.2007Examination requested  [2008/10]
28.02.2008Amendment by applicant (claims and/or description)
19.05.2009Despatch of a communication from the examining division (Time limit: M04)
28.09.2009Reply to a communication from the examining division
11.02.2010Communication of intention to grant the patent
07.06.2010Fee for grant paid
07.06.2010Fee for publishing/printing paid
Opposition(s)06.05.2011No opposition filed within time limit [2011/28]
Fees paidRenewal fee
23.06.2008Renewal fee patent year 03
19.06.2009Renewal fee patent year 04
21.06.2010Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT04.08.2010
BE04.08.2010
CY04.08.2010
CZ04.08.2010
DK04.08.2010
EE04.08.2010
FI04.08.2010
HU04.08.2010
IT04.08.2010
LT04.08.2010
LV04.08.2010
NL04.08.2010
PL04.08.2010
RO04.08.2010
SE04.08.2010
SI04.08.2010
SK04.08.2010
TR04.08.2010
BG04.11.2010
GR05.11.2010
IS04.12.2010
PT06.12.2010
[2013/45]
Former [2013/44]AT04.08.2010
BE04.08.2010
CY04.08.2010
CZ04.08.2010
DK04.08.2010
EE04.08.2010
FI04.08.2010
IT04.08.2010
LT04.08.2010
LV04.08.2010
NL04.08.2010
PL04.08.2010
RO04.08.2010
SE04.08.2010
SI04.08.2010
SK04.08.2010
TR04.08.2010
BG04.11.2010
GR05.11.2010
IS04.12.2010
PT06.12.2010
Former [2011/29]AT04.08.2010
BE04.08.2010
CY04.08.2010
CZ04.08.2010
DK04.08.2010
EE04.08.2010
FI04.08.2010
IT04.08.2010
LT04.08.2010
LV04.08.2010
NL04.08.2010
PL04.08.2010
RO04.08.2010
SE04.08.2010
SI04.08.2010
SK04.08.2010
BG04.11.2010
GR05.11.2010
IS04.12.2010
PT06.12.2010
Former [2011/23]AT04.08.2010
BE04.08.2010
CY04.08.2010
CZ04.08.2010
DK04.08.2010
EE04.08.2010
FI04.08.2010
LT04.08.2010
LV04.08.2010
NL04.08.2010
PL04.08.2010
SE04.08.2010
SI04.08.2010
SK04.08.2010
BG04.11.2010
GR05.11.2010
IS04.12.2010
PT06.12.2010
Former [2011/19]AT04.08.2010
BE04.08.2010
CY04.08.2010
DK04.08.2010
FI04.08.2010
LT04.08.2010
LV04.08.2010
NL04.08.2010
PL04.08.2010
SE04.08.2010
SI04.08.2010
BG04.11.2010
GR05.11.2010
IS04.12.2010
PT06.12.2010
Former [2011/18]AT04.08.2010
BE04.08.2010
CY04.08.2010
FI04.08.2010
LT04.08.2010
LV04.08.2010
NL04.08.2010
PL04.08.2010
SE04.08.2010
SI04.08.2010
BG04.11.2010
GR05.11.2010
IS04.12.2010
PT06.12.2010
Former [2011/09]AT04.08.2010
LT04.08.2010
NL04.08.2010
Documents cited:Search[X]EP0206065  (FERAMISCO JAMES R [US], et al) [X] 1-26 * the whole document * * claim 1 * * example 1 * * page 10, lines 23-25 * * page 11, line 15 - line 20 *;
 [X]EP0214520  (ONCOGENE SCIENCE INC [US]) [X] 1-26 * the whole document * * claims 1-104 * * claim 93 * * page 5, line 8 - line 15 * * page 14, line 30 - page 15, line 15 *;
 [DX]US5443956  (CARNEY WALTER P [US]) [DX] 1-26 * the whole document * * abstract * * column 6 * * column 8, line 13 - line 24 * * example 7 *;
 [A]US2003219842  (CARNEY WALTER P [US], et al) [A] 1-26 * the whole document ** claims 1,9,13,27,43,50 *;
 [DX]  - RUNDLE ANDREW ET AL, "Association between the ras p21 oncoprotein in blood samples and breast cancer", CANCER LETTERS, (20021108), vol. 185, no. 1, ISSN 0304-3835, pages 71 - 78, XP002486942 [DX] 1-26 * the whole document * * page 72, column 2, paragraph 3 - page 73, column 2 * * table 2 * * page 77, column 1 *

DOI:   http://dx.doi.org/10.1016/S0304-3835(02)00236-7
 [A]  - FURTH M E ET AL, "MONOCLONAL ANTIBODIES TO THE P21 PRODUCTS OF THE TRANSFORMING GENE OF HARVEY MURINE SARCOMA VIRUS AND OF THE CELLULAR RAS GENE FAMILY", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, (19820701), vol. 43, no. 1, ISSN 0022-538X, pages 294 - 304, XP008041021 [A] 1-26 * the whole document * * page 301, column 1 *
 [A]  - GULBIS BEATRICE ET AL, "Immunodetection of the p21-ras products in human normal and preneoplastic tissues and solid tumors: A review", HUMAN PATHOLOGY, (1993), vol. 24, no. 12, ISSN 0046-8177, pages 1271 - 1285, XP002486943 [A] 1-26 * the whole document * * table 1 *

DOI:   http://dx.doi.org/10.1016/0046-8177(93)90260-N
International search[Y]  - RUNDLE A. ET AL., "Association between the ras p21 oncoprotein in blood samples and breast cancer", CANCER LETTERS, (2002), vol. 185, pages 71 - 78, XP002486942

DOI:   http://dx.doi.org/10.1016/S0304-3835(02)00236-7
by applicant   - WILHELM ET AL., CANCER RESEARCH, (20041001), vol. 64, pages 7099 - 7109
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.